The spectrum of clinical and genetic findings in hereditary leiomyomatosis and renal cell cancer (HLRCC) with relevance to patient outcomes: a retrospective study from a large academic tertiary referral center.

Scharnitz, Thomas; Nakamura, Mio; Koeppe, Erika; Henry, Marie-Louise; Lowe, Lori; Else, Tobias; Cha, Kelly B

Scharnitz, Thomas; Nakamura, Mio; Koeppe, Erika; Henry, Marie-Louise; Lowe, Lori; Else, Tobias; Cha, Kelly B.

Afiliação

Scharnitz T; Dermatology and Laser Center of Charleston SC 29414, USA.
Nakamura M; Department of Dermatology, University of Michigan MI 48109, USA.
Koeppe E; Department of Internal Medicine, University of Michigan MI 48109, USA.
Henry ML; Cancer Center, University of Michigan MI 48109, USA.
Lowe L; Department of Pathology, University of Michigan MI 48109, USA.
Else T; Department of Internal Medicine, University of Michigan MI 48109, USA.
Cha KB; Department of Dermatology, University of Michigan MI 48109, USA.

Am J Cancer Res ; 13(1): 236-244, 2023.

Article em En | MEDLINE | ID: mdl-36777509

Palavras-chave

Hereditary leiomyomatosis and renal cell cancer; cutaneous leiomyoma; cutaneous leiomyosarcoma; fumarate hydratase; genetic variants; reed syndrome; renal cell cancer; uterine leiomyoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article